| Patents for A61K 36 - Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines (179,316) |
|---|
| 01/23/2002 | EP1173476A1 Soybean protein nutraceuticals |
| 01/23/2002 | EP1173165A1 Cardiovascular and bone treatment using isoflavones |
| 01/23/2002 | EP1173162A1 Compositions of boswellic acids derived from boswellia serrata gum resin, for treating lymphoproliferative and autoimmune conditions |
| 01/23/2002 | EP1173159A1 Composition and method useful for treating colic |
| 01/23/2002 | EP1173158A1 Compounds useful in reducing the level of insulin like growth factor-1 (igf-1) in blood |
| 01/23/2002 | EP1173149A1 Cosmetic and/or dietetic composition comprising a mixture of lycopene and olive leaf extract |
| 01/23/2002 | EP1173145A1 Composition for cosmetic and dermatological skin care |
| 01/23/2002 | EP1173071A1 Ginseng berry health products |
| 01/23/2002 | EP1173070A1 Cactus fruit health products |
| 01/23/2002 | EP0941103B1 Pharmaceutical composition for treatment of diabetes |
| 01/23/2002 | CN1332847A Substance containing shiitake mushroom hypha extract for soreening lak activity and method for screening lak activity by using the same |
| 01/23/2002 | CN1332634A Gamma & T cell immunoactivity potentiators containing shiitake mushroom hypha extract |
| 01/23/2002 | CN1332632A Preventives for hepatopathy |
| 01/23/2002 | CN1078088C Solvent extraction process |
| 01/22/2002 | US6340485 Compositions and uses thereof |
| 01/22/2002 | US6340484 Solid pesticide, storage stability |
| 01/22/2002 | US6340483 Antiviral composition derived from allium CEPA and therapeutic use thereof |
| 01/22/2002 | US6340482 Administering by mouth adrenergic amine or amines selected from the group consisting of synephrine, hordenine, octopamine, tyramine and n-methyltyramine for suppressing hunger for inducing weight loss |
| 01/22/2002 | US6340481 Administering by mouth to a human formulation comprising adrenergic amine or amines selected from the group consisting of synephrine, hordenine, octopamine, tyramine and n-methyltyramineenhancing physical performance in a human |
| 01/22/2002 | US6340480 Natural composition for the treatment of circulatory conditions |
| 01/22/2002 | US6340479 Stable, homogeneous, extract free or nearly free form secondary reaction products |
| 01/22/2002 | US6340478 Storage stability |
| 01/22/2002 | US6340476 Pharmaceutical dosage form for pulsatile delivery of methylphenidate |
| 01/22/2002 | US6340456 For oral hygiene, drugs |
| 01/18/2002 | CA2353677A1 Use of at least one extract of at least one iris in a composition intended to stimulate immune defence |
| 01/17/2002 | WO2002004623A2 ANTISENSE COMPOSITIONS TARGETED TO β1 ADRENOCEPTOR-SPECIFIC MRNA AND METHODS OF USE |
| 01/17/2002 | WO2002004003A2 Composition for the treatment of osteoarthritis |
| 01/17/2002 | WO2002004000A1 Potent immunostimulants from microalgae |
| 01/17/2002 | WO2002003999A1 High molecular weight polysaccharide fraction from aloe vera with immunostimulatory activity |
| 01/17/2002 | WO2002003945A1 Use of oligosaccharides to stimulate beta-endorphin production |
| 01/17/2002 | WO2001068138A3 Intradermal-penetration agents for topical local anesthetic administration |
| 01/17/2002 | WO2001058412A3 Extracts from residues left in the production of wine |
| 01/17/2002 | WO2001041775A3 Use of procyanidins in the maintenance of vascular health and modulation of the inflammatory response |
| 01/17/2002 | WO2001032830A3 Process for producing, methods and compositions of glucuronoxylomannan as nutriceutical agent from higher basidiomycetes mushroom |
| 01/17/2002 | US20020006955 Ginkgolides for inhibition of membrane expression of benzodiazepine receptors |
| 01/17/2002 | US20020006911 Administering mixture of jasmone, antioxidant and carnitine |
| 01/17/2002 | US20020006449 By applying Capsaicin topically, where disappearance, atrophication and de-coloration of treated area is achieved |
| 01/17/2002 | US20020006448 Compositions and methods for treating back and leg discomfort |
| 01/17/2002 | US20020006447 Anti-chlamydia agent |
| 01/17/2002 | US20020006446 Five medicinal plants from Thailand, comprising Houttuynia cordata, Combretum quadrangulare, Mimusops elengi, Randia siamensis, and Borassus flabellifer; maintain Kamofsky performance status greater than or equal to ninety |
| 01/17/2002 | US20020006445 Composition and method for treating the effects of diseases and maladies |
| 01/17/2002 | US20020006444 Extract from a plant crude drug, having given amount of soluble silicon compound calculated as silicon per gram of dry weight, and extract that inhibits production of plasma kallikrein; standardization |
| 01/17/2002 | US20020006416 Use of an extract of gaboon resin |
| 01/17/2002 | US20020006414 External composition for skin comprising sphingoglycolipid |
| 01/17/2002 | US20020006411 Vaccines expressed in plants |
| 01/17/2002 | US20020006383 Promoter of biosynthesis of skin cells |
| 01/17/2002 | DE10031651A1 Extrakte aus Sophora-Arten, Verfahren zu ihrer Herstellung und Verwendung Extracts of Sophora species, processes for their preparation and use |
| 01/17/2002 | DE10031650A1 Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden The use of extracts from Sophora flavescens or Sophora subprostrata for the prophylaxis and treatment of pathological conditions caused by estrogen deficiency or by other hormonal dysregulation |
| 01/17/2002 | CA2415483A1 Antisense compositions targeted to .beta.1 adrenoceptor-specific mrna and methods of use |
| 01/16/2002 | EP1172112A2 Preventive, alleviative or remedy for hypertension |
| 01/16/2002 | EP1172111A1 Pharmaceutical composition with adhesion molecule expression regulating activity |
| 01/16/2002 | EP1172094A1 Composition, particularly for cosmetics, comprising DHEA and/or precursor or derivative, and at least a compound which increases the synthesis of glycosaminoglycans |
| 01/16/2002 | EP1172091A1 Skin dyeing compositions containing flavylium salt compounds non substituted in position 3 |
| 01/16/2002 | EP1172087A2 Topical treatment of skin |
| 01/16/2002 | EP1171455A1 Polypeptide-k obtained from momordica charantia and a process for the extraction thereof |
| 01/16/2002 | EP1171146A1 Pharmaceutical compositions containing selegiline and ginkgo biloba extract useful for dementia |
| 01/16/2002 | EP1171145A1 Use of catechin for preventing or treating coronary restenosis |
| 01/16/2002 | EP1171144A1 Use of tetrahydrocurcuminoids to regulate physiological and pathological events in the skin and mucosa |
| 01/16/2002 | EP1171143A1 Peptide extract of lupine and pharmaceutical or cosmetic or nutritional composition comprising same |
| 01/16/2002 | EP1171142A1 Inflammatory mediation obtained from atractylodes lancea |
| 01/16/2002 | EP1171130A1 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 01/16/2002 | EP1171119A1 Methods of treating clinical diseases with isoflavones |
| 01/16/2002 | EP1121926A9 Cosmetic preparations containing Waltheria indica extracts |
| 01/16/2002 | EP1014934B1 Use of at least an extract of the genus chrysanthemum for stimulating skin and/or hair pigmentation |
| 01/16/2002 | EP1007067B1 Pharmaceutical compositions containing parthenium integrifolium or parts thereof or an extract or component thereof, the use of such plant material for preparing certain medicines, and a method of preparing an extract of parthenium integrifolium |
| 01/16/2002 | EP0973495B1 Use of bambara nut seed extract(s) in a cosmetic composition |
| 01/16/2002 | EP0952839B1 Green ointment |
| 01/16/2002 | EP0772434B1 Method of preparing natural-oil-containing emulsions and microcapsules and its uses |
| 01/16/2002 | CN1331681A Synthesis of histamine dihydrochloride |
| 01/16/2002 | CN1331601A Antiprotozoal saponins |
| 01/16/2002 | CN1331600A Herbal and pharmaceutical drugs enhanced with probiotics |
| 01/16/2002 | CN1331558A Orally immunogenic bacterial enterotoxins expressed in transgenic plants |
| 01/15/2002 | US6338862 Composition and method of use in treating sexual dysfunction using cGMP-specific phosphodiesterase type 5 inhibitors |
| 01/15/2002 | US6338856 Seaweed supplement diet for enhancing immune response in mammals and poultry |
| 01/15/2002 | US6338850 Administering immunosuppressive dosage of plant tissue and purification |
| 01/15/2002 | CA2050946C Use of polysaccharides in preparations for wound treatment |
| 01/13/2002 | CA2353057A1 Topical treatment of skin |
| 01/12/2002 | CA2352605A1 Formulations containing non-substitute flavylium-salt-type compounds in position 3 for skin colouring and uses |
| 01/10/2002 | WO2002002607A2 Acid-modified arabinogalactan protein composition |
| 01/10/2002 | WO2002002129A1 Use of grifola frondosa fungus extracts |
| 01/10/2002 | WO2002002106A1 Use of modified tall oil in combination with dietary supplements to improve body composition and health status |
| 01/10/2002 | WO2002002068A2 Cosmetic skin care compositions and containing gum mastic |
| 01/10/2002 | WO2001050881A3 Process and composition for controlling fecal hair excretion and trichobezoar formation |
| 01/10/2002 | WO2001039656A3 Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia |
| 01/10/2002 | US20020004523 Partially purified cocoa extracts containing cocoa polyphenols |
| 01/10/2002 | US20020004079 Contacting raw materials with low boiling c1-4 fluorohydrocarbons reduces the risk of loosing desired product and obtaining undesired product during distillation; pesticides and plant extracts from raw materials |
| 01/10/2002 | US20020004078 Composition and method for treating the effects of diseases and maladies |
| 01/10/2002 | US20020004077 Antioxidant compositions extracted from olives and olive by-products |
| 01/10/2002 | US20020004076 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 01/10/2002 | US20020004075 Anti-cancer extracts and pharmaceutical compositions and methods |
| 01/10/2002 | US20020004073 Condensing in presence of catalytic thiol unoxidized sulfhydryl side chain of n-terminal cysteine of one oligopeptide with c-terminal thioester of other to produce intermediate bond, then rearranging to produce amide bond |
| 01/10/2002 | US20020004049 Tryptophan source from plants and uses therfor |
| 01/10/2002 | DE10030139A1 Verwendung von Phyllanthusbesandteilen zur Behandlung oder Prophylaxe von Infekten durch Flaviviridae Using Phyllanthusbesandteilen for the treatment or prophylaxis of infections by Flaviviridae |
| 01/10/2002 | CA2413166A1 Acid-modified arabinogalactan protein composition |
| 01/09/2002 | EP1170015A1 Use of extracts of the fungus Grifola frondosa |
| 01/09/2002 | EP1170014A1 Proteoglycan, a bioactive substance from plants |
| 01/09/2002 | EP1170013A1 Drugs, foods, drinks and feeds containing cocoa component |
| 01/09/2002 | EP1170006A1 Drugs for relieving hemicrania |
| 01/09/2002 | EP1169056A1 Caspase inhibitors for inhibiting blood cell proliferation and for treating autoimmune diseases |
| 01/09/2002 | EP1169047A1 Compositions and methods for treatment of diabetes |